Journal of Bioequivalence & Bioavailability

Journal of Bioequivalence & Bioavailability
Open Access

ISSN: 0975-0851

+32-466-902163

Lipika Chablani

Lipika Chablani

Lipika Chablani
Department of Pharmaceutical Sciences, St. John Fisher College
USA

Biography

Dr. Lipika Chablani is currently Assistant Professor at Wegmans School of Pharmacy, St. John Fisher College, Rochester NY. She owns a B.S in Pharmacy from University of Mumbai, India. After completion of her B.S. in Pharmacy, she moved on to pursue a Master’s degree at Campbell University, School of Pharmacy and Health Sciences, North Carolina. During her Master’s program she worked with the Research and Development team of GlaxoSmithKline (NC) to evaluate two Process Analytical Tools (PATs) to optimize granulation process for tablet manufacturing. She has successfully published a research paper in AAPS PharmSciTech journal on this collaborative thesis work. Dr. Chablani further graduated with a Ph.D. in Pharmaceutical Sciences from Mercer University College of Pharmacy and Health Sciences in 2012. Her Ph.D. dissertation was focused on formulation and evaluation of particulate breast cancer vaccines. Dr. Chablani owns publications in distinguished journals for her research work at Mercer University. During her tenure at Mercer University, she also collaborated with Abbott Pharmaceuticals (IL) and Emory University (GA) for industrial and research projects. She also completed the ACPE accredited Pharmacy Teaching Certificate program at Mercer University in 2011. Dr. Chablani is involved in co-teaching three courses at Wegmans School of Pharmacy: Applied Pharmaceutics laboratory, Principles of Pharmaceutical Sciences and Pharmaceutics. Along with teaching, she plans to foster her research interests in the field of oncology and immunology as she continues her research against breast cancer. Dr. Chablani is also an active member of AAPS, AACP and Toastmasters International.

Research Interest

Owing to a strong research background of formulation development and evaluation of dosage forms and novel drug delivery systems, I have an inclination to continue my research in the field of nanotechnology targeted towards providing preventive and therapeutic solutions for cancer. Cancer is one of the leading causes of mortality, I believe utilizing immunotherapy and preparing vaccines against it, which can either be used prophylactically or therapeutically will provide a potential solution. Particulate delivery systems are unique in their nature as they provide a broad range of applications based on their size and composition. My research involves usage of such particulate delivery systems as a carrier for various cancer antigens. Having dealt with formulation optimization of such particulate systems in past, my research will build on exploring various types of vaccines which can be formulated in such micro/nano particles. Another aspect of my research is the route of administration for such vaccines. The route of administration plays a vital role in induction of immune response against any disease model and to study it further to develop a patient compliant vaccine is part my research goals. My research lab at Wegmans School of Pharmacy is well equipped and is open for any collaboration in the field of oncology and immunology.

Top